Toru Arai

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Extracorporeal Membrane Oxygenation

Idiopathic Pulmonary Fibrosis

Monoclonal Antibody

Top Venues

Canadian respiratory journal

Respirology (Carlton, Vic.)

Journal of clinical medicine

Orphanet journal of rare diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Takayuki Takimoto, Hiromitsu Sumikawa, Yoshikazu Inoue, Toru Arai
Autofluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome: Negative Autofluorescence Sign. American journal of respiratory and critical care medicine 210 (5) (2024)
Takayuki Takimoto, Hiromitsu Sumikawa, Yoshikazu Inoue, Toru Arai
Autofluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome: Negative Autofluorescence Sign. American journal of respiratory and critical care medicine 210 (5) (2024)
Toru Arai, Yu Kurahara, Mitsuhiro Moda, Takehiko Kobayashi, Yoshinobu Matsuda, Tomoko Kagawa, Reiko Sugawara, Kazunari Tsuyuguchi, Yoshikazu Inoue
COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy. Journal of clinical medicine 12 (15) (2023)
Kazunobu Tachibana, Masanori Akira, Toru Arai, Chikatoshi Sugimoto, Seiji Hayashi, Yoshikazu Inoue
Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis. Canadian respiratory journal 2023 (2023)
Toru Arai, Takayuki Takimoto, Naoko Takeuchi, Shojiro Minomo, Tomoko Kagawa, Yoshikazu Inoue
Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Journal of clinical medicine 12 (23) (2023)
Kazunobu Tachibana, Masanori Akira, Toru Arai, Chikatoshi Sugimoto, Seiji Hayashi, Yoshikazu Inoue
Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis. Canadian respiratory journal 2023 (2023)
Kazunobu Tachibana, Masanori Akira, Toru Arai, Chikatoshi Sugimoto, Seiji Hayashi, Yoshikazu Inoue
Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis. Canadian respiratory journal 2023 (2023)
Kazunobu Tachibana, Masanori Akira, Toru Arai, Chikatoshi Sugimoto, Seiji Hayashi, Yoshikazu Inoue
Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis. Canadian respiratory journal 2023 (2023)
Kazunobu Tachibana, Masanori Akira, Toru Arai, Chikatoshi Sugimoto, Seiji Hayashi, Yoshikazu Inoue
Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis. Canadian respiratory journal 2023 (2023)
Toru Arai, Masaki Hirose, Yoshimasa Hamano, Tomoko Kagawa, Akihiro Murakami, Hiroshi Kida, Atsushi Kumanogoh, Yoshikazu Inoue
Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis. Canadian respiratory journal 2022 (2022)
Toru Arai, Yoshikazu Inoue
Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist. ERJ open research 8 (3) (2022)
Toru Arai, Hiroshi Kida, Yoshitaka Ogata, Satoshi Marumo, Hiroto Matsuoka, Iwao Gohma, Suguru Yamamoto, Masahide Mori, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Yoshikazu Inoue
Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial. BMJ open respiratory research 7 (1) (2021)
Toru Arai, Hiroto Matsuoka, Masaki Hirose, Hiroshi Kida, Suguru Yamamoto, Yoshitaka Ogata, Masahide Mori, Kazuyoshi Hatsuda, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Yoshikazu Inoue
Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin. BMJ open respiratory research 8 (1) (2021)
Toru Arai, Tomoko Kagawa, Yumiko Sasaki, Reiko Sugawara, Chikatoshi Sugimoto, Kazunobu Tachibana, Yoshiki Fujita, Seiji Hayashi, Yoshikazu Inoue
Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage: Predictive Role for Acute Exacerbation of Idiopathic Interstitial Pneumonias. Canadian respiratory journal 2021 (2021)
Teiko Sakurai, Toru Arai, Masaki Hirose, Kensuke Kojima, Tetsuki Sakamoto, Yoshinobu Matsuda, Chikatoshi Sugimoto, Hyung-Eun Yoon, Yoshikazu Inoue
Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis. Orphanet journal of rare diseases 16 (1) (2021)
Takayuki Takimoto, Tomoko Kagawa, Kazunobu Tachibana, Toru Arai, Yoshikazu Inoue
Massive atelectasis by mucoid impaction in an asthma patient during treatment with anti-interleukin-5 receptor antibody. Respirology case reports 8 (6) (2020)
Toru Arai, Yoshikazu Inoue
Is corticosteroid use truly not associated with improved outcomes in AE-IPF? Respirology (Carlton, Vic.) 25 (6) (2020)
Kanako Katayama, Masaki Hirose, Toru Arai, Kazuyoshi Hatsuda, Kazunobu Tachibana, Reiko Sugawara, Chikatoshi Sugimoto, Takahiko Kasai, Masanori Akira, Yoshikazu Inoue
Clinical significance of serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis. Orphanet journal of rare diseases 15 (1) (2020)
Toru Arai, Hiroshi Kida, Yoshitaka Ogata, Satoshi Marumo, Hiroto Matsuoka, Iwao Gohma, Suguru Yamamoto, Masahide Mori, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Ryuya Edahiro, Toshimitsu Hamasaki, Yoshikazu Inoue, null null
Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias. Respirology (Carlton, Vic.) 24 (7) (2019)
Toru Arai, Yoshikazu Inoue
Corticosteroids in acute exacerbations of idiopathic interstitial pneumonias: Time to debate - Reply. Respirology (Carlton, Vic.) 23 (5) (2018)
Toru Arai, Kazunobu Tachibana, Chikatoshi Sugimoto, Yoshikazu Inoue, Sayoko Tokura, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi, Seiji Hayashi, Yoshikazu Inoue
High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias. Respirology (Carlton, Vic.) 22 (7) (2017)